medmix AG (SWX:MEDX)

Switzerland flag Switzerland · Delayed Price · Currency is CHF
8.86
-0.06 (-0.67%)
Jun 3, 2026, 9:30 AM CET
Market Cap362.80M -16.1%
Revenue (ttm)448.00M -7.4%
Net Income6.40M
EPS0.15
Shares Out 40.67M
PE Ratio59.47
Forward PE16.71
Dividend0.10 (1.13%)
Ex-Dividend DateApr 20, 2026
Volume3,854
Open8.86
Previous Close8.92
Day's Range8.82 - 8.88
52-Week Range8.10 - 13.02
Beta0.79
AnalystsStrong Buy
Price Target15.97 (+80.25%)
Earnings DateJul 23, 2026

About medmix AG

medmix AG designs, produces, and sells high-precision devices and services in Switzerland and internationally. It operates through the Healthcare, and Consumer and Industrial segments. The company offers dispensers, cartridges, mixers, tips, syringes, pen, and auto injectors for delivery of dental materials; delivery devices and mixing for bone repair and tissue treatment, which are used for prosthetics, restoratives, anesthetics, and aesthetics; the pen and auto injectors, which are used in fertility and growth hormone treatments, treatment of... [Read more]

Founded 1922
Employees 2,574
Stock Exchange SIX Swiss Exchange
Ticker Symbol MEDX
Full Company Profile

Financial Performance

Financial Statements

News

medmix AG Earnings Call Transcript: H2 2025

Gross profit and margins improved year-over-year despite revenue declines, driven by cost savings and strong dental performance. Guidance for 2026 is cautious, with flat to low single-digit organic growth and margin stability, as dual sourcing and tariffs remain headwinds.

3 months ago - Transcripts

medmix AG Annual report: H2 2025

medmix AG has published its H2 2025 annual report on February 26, 2026.

3 months ago - Filings

medmix AG Earnings release: H2 2025

medmix AG released its H2 2025 earnings on February 26, 2026, summarizing the period's financial results.

3 months ago - Filings

medmix AG Slides: H2 2025

medmix AG has posted slides in relation to its H2 2025 quarterly earnings report, which was published on February 26, 2026.

3 months ago - Filings

medmix AG Earnings Call Transcript: H1 2025

Gross profit and profitability improved above guidance despite lower revenues, driven by cost savings and efficiency gains. Dental and Surgery segments outperformed, while Beauty and Industry faced headwinds. Full-year revenue is expected to decline, but margin guidance is maintained.

11 months ago - Transcripts

medmix AG Quarterly report: H1 2025

medmix AG has published its H1 2025 quarterly earnings report on July 23, 2025.

11 months ago - Filings

medmix AG Slides: H1 2025

medmix AG has posted slides in relation to its H1 2025 quarterly earnings report, which was published on July 23, 2025.

11 months ago - Filings